Showing results (741-750 of 782) with videos related to

Sort By:
Pageof 79
Blood|December 17, 2013
Mutation of NRAS but not KRAS significantly reduces myeloma sensitivity to single-agent bortezomib therapyGeorge Mulligan, David I Lichter, Alessandra Di Bacco, et al.
Blood|March 29, 2024
Loss of GABARAP mediates resistance to immunogenic chemotherapy in multiple myelomaAnnamaria Gulla, Eugenio Morelli, Megan Johnstone, et al.
Blood|July 29, 2026
A first-in-class RNA degrader reduces c-MYC expression and myeloma cell survival in preclinical modelsDomenico Maisano, Tenghui Wang, Steffen Benham Kulp, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 10, 2016
NCCN Guidelines Insights: Multiple Myeloma, Version 3.2016Kenneth C Anderson, Melissa Alsina, Djordje Atanackovic, et al.
Leukemia|January 14, 2022
Cell-free DNA for the detection of emerging treatment failure in relapsed/ refractory multiple myelomaJohannes M Waldschmidt, Andrew J Yee, Tushara Vijaykumar, et al.
The Journal of Experimental Medicine|July 27, 2016
BCL-B (BCL2L10) is overexpressed in patients suffering from multiple myeloma (MM) and drives an MM-like disease in transgenic miceMohamed-Amine Hamouda, Arnaud Jacquel, Guillaume Robert, et al.
Nature Chemical Biology|October 3, 2017
Inhibition of USP10 induces degradation of oncogenic FLT3Ellen L Weisberg, Nathan J Schauer, Jing Yang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 11, 2015
Multiple Myeloma, Version 2.2016: Clinical Practice Guidelines in OncologyKenneth C Anderson, Melissa Alsina, Djordje Atanackovic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2015
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working GroupAntonio Palumbo, Hervé Avet-Loiseau, Stefania Oliva, et al.
Pageof 79